Evidence map›Paper›PMID 15466389›Full record

ArticleThe American journal of pathology2004

Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.

Heike Steiling, Marcus Mühlbauer, Frauke Bataille, Jürgen Schölmerich, Sabine Werner, Claus Hellerbrand

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Hepatic progenitor cell activation in liver repair.Liver research (Beijing, China) · 2017
    Article
  6. Article
  7. Review
  8. Review
  9. Cancer-associated fibroblasts in digestive tumors.World journal of gastroenterology · 2014
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Epigenetic cell fate regulation of hepatic stellate cells.Hepatology research : the official journal of the Japan Society of Hepatology · 2011
    Article
  16. Mechanisms of hepatic fibrogenesis.Best practice & research. Clinical gastroenterology · 2011
    Review
  17. Article
  18. Article
  19. Article
  20. Advances in antifibrotic therapy.Expert review of gastroenterology & hepatology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Heike SteilingDepartment of Biology, Institute of Cell Biology, Swiss Federal Institute of Technology, Zurich, Switzerland.
Marcus Mühlbauer
Frauke Bataille
Jürgen Schölmerich
Sabine Werner
Claus Hellerbrand
University of Regensburg · DEÉcole Polytechnique Fédérale de Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratinocyte growth factor (KGF), a member of the fibroblast growth factor (FGF) family, is a specific mitogen for different types of epithelial cells and a potent survival factor for these cells under stress conditions. KGF expression increases strongly after injury to various tissues, including the skin and the intestine, and signaling via the KGF receptor was shown to be crucial for repair of skin wounds and for liver regeneration. Here we demonstrate an increased expression of KGF in chronic liver disease associated with fibrosis. The extent of KGF overexpression correlated strongly with the stage of fibrosis. As the cellular source of KGF we identified activated hepatic stellate cells (HSCs)/myofibroblasts. In contrast to the ligand, the KGF receptor, FGFR2-IIIb, was exclusively expressed by hepatocytes, but not by activated HSCs or other parenchymal or nonparenchymal liver cells. Based on the known effects of KGF on hepatocytes in vitro, our findings suggest that HSC/myofibroblast-derived KGF may enhance liver regeneration and/or hepatocyte survival in patients with chronic liver disease.

Indexed as

AnimalsCarbon TetrachlorideCells, CulturedDisease Models, AnimalFibroblast Growth Factor 7Fibroblast Growth FactorsFibroblastsHepatocytesHumansImmunohistochemistryLiverLiver CirrhosisLiver DiseasesReceptor, Fibroblast Growth Factor, Type 2Receptors, Fibroblast Growth FactorReverse Transcriptase Polymerase Chain ReactionCarbon TetrachlorideFGF7 protein, humanFibroblast Growth Factor 7Fibroblast Growth FactorsReceptor, Fibroblast Growth Factor, Type 2Receptors, Fibroblast Growth FactorRNA, Messenger

Identifiers

PMID15466389
PMCPMC1618645
OpenAlexW2026816833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.